Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-15-00366R2_FINAL_Burgess_15082016.pdf
[2] http://www.ncbi.nlm.nih.gov/pubmed/?term=OPTIMISING%20BETA-LACTAM%20PHARMACODYNAMICS%20AGAINST%20PSEUDOMONAS%20AERUGINOSA%20IN%20ADULT%20CYSTIC%20FIBROSIS%20PATIENTS
[3] https://www.ecfs.eu/research-article-themes/microbiology
[4] https://www.ecfs.eu/research-article-keywords/beta-lactam
[5] https://www.ecfs.eu/research-article-keywords/continuous-infusion
[6] https://www.ecfs.eu/research-article-keywords/pharmacodynamics
[7] https://www.ecfs.eu/research-article-keywords/pharmacokinetics
[8] https://www.ecfs.eu/research-article-keywords/prolonged-infusion
[9] https://www.ecfs.eu/research-article-keywords/pseudomonas-aeruginosa